CDTX vs V · rev $1.3M vs P/E 33, rev $40.00B
Cidara Therapeutics Inc (CDTX) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
CDTX currently screens at market cap $6.96B. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the CDTX and V stock pages for the full models.
Not investment advice.